Langerhans cell sarcoma (LCS) and quintuple cancers are extremely rare. In this report, a case of quintuple cancers including LCS was described. An 80-year-old man had squamous cell carcinoma of the nasal skin, colon and rectum adenocarcinomas, and T-cell/histiocyte-rich large B-cell lymphoma. As swelling of multiple submental lymph nodes was observed, fine-needle aspiration was carried out. Many large cells with high-grade nuclear atypia and abundant cytoplasm were observed. Lymphocytes and eosinophils were observed in the background. Although a malignant tumor was suspected, a definite diagnosis could not be made. In a biopsy sample, the tumor cells were positive for vimentin, CD68, S-100, CD1a, and CD163 and negative for epithelial, lymphocyte, and melanoma markers in immunohistochemistry. A diagnosis of LCS was made from the immunohistochemical findings and high mitotic rate with atypical forms. The patient died about 2 months after the first medical examination. Metastasis of LCS was confirmed in many organs by autopsy.
Langerhans cells (LCs) are antigen-presenting dendritic cells. According to the recent World Health Organization (WHO) classification, 1 LC tumors have been difficult to differentiate from histologically diagnosed non-Hodgkin lymphoma, melanoma, sarcoma, and undifferentiated carcinomas due to their similarities. Immunostaining for CD1a, S-100 protein, CD163, and langerin (CD207) is useful for establishing a diagnosis of LC tumor. LC tumors are classified into Langerhans cell histiocytosis (LCH) and Langerhans cell sarcoma (LCS). Differential diagnosis between LCH and LCS is based on malignant potential. Although diagnosis is difficult due to the similarity of cytological and histological features, mitotic activity would become a differential point. In LCH, mitotic activity is variable and without atypical forms. The mitotic rate of LCS is high, usually >50 per 10 high-power field (HPF). LCS is extremely rare. [1] [2] [3] It can appear in any age group (range, 2-88 years), and it is predominant in females.
1 LCS occurs commonly in the skin, soft tissue, and lymph nodes with multiorgan involvement including the liver, spleen, lungs, and bones. [1] [2] [3] The organs most frequently involved are the skin (about 60% of cases) and lymph nodes (about 50% of cases). 2 Patients presenting with multiorgan involvement have a very poor prognosis. 2 Early detection and accurate diagnosis are important for improving the This is an open access article under the terms of the Creative Commons Attribution NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
1 Department of Pathology, Kushiro City General Hospital, Syunkodai 1-12, Kushiro 085-0822, Japan prognosis. However, there has been only one report on cytological findings of LCS. 3 Although BRAF mutations in histiocytic proliferative diseases are restricted to lesions of LC type, the positive rate of BRAF mutations in LCS is lower than that in LCH. 4 Quintuple primary cancers are rare. [5] [6] [7] [8] [9] [10] [11] We experienced a case of quintuple tumors including LCS. It was difficult to make a diagnosis of LCS by fine-needle aspiration (FNA) of a neck lymph node. We report the cytological findings of LCS by FNA and touch smear cytology.
Case Report

Clinical Summary
An 80-year-old Japanese man was admitted to our hospital with a nasal skin tumor. He had past medical histories of adenocarcinomas and T-cell/histiocyte-rich large B-cell lymphoma. His family history was unremarkable. Swelling of multiple submental lymph nodes was revealed by computed tomography (Fig. 1A) . The diameter of a lymph node was 16 mm (Fig. 1B) . Diagnosis by FNA of a lymph node was difficult. A diagnosis of LCS was made by biopsy. The condition of the patient rapidly deteriorated and he died about 2 months after the first medical examination. Metastasis of LCS was confirmed in many organs by autopsy. Written informed consent was obtained from his daughter. The study was approved by the Institutional Review Boards of Kushiro City General Hospital.
Cytological Findings
Many large cells were found with mature lymphocytes by FNA from the swelling lymph node ( Figs. 2A and B) . The large cells had abundant cytoplasm. Nuclei were pleomorphic. These atypical cells had nuclear grooves ( Fig. 2B ; red arrow). Multinucleated cells were observed ( Fig. 2B ; green arrow). These neoplastic cells had fine chromatin granules in touch smear cytology of the lymph node biopsy (Figs. 2C and D). These atypical cells had a small nucleolus, and mitosis was observed (Figs. 2C and D; yellow arrow). There was no atypical mitosis. Several nuclear inclusion bodies were also confirmed (Figs. 2C and D; light blue arrow). There were many eosinophils and mature lymphocytes in the background. The possibility of malignant lymphoma or histiocytic neoplasm was considered. However, the possibility of poorly differentiated carcinoma or malignant melanoma could not be completely ruled out. Because we failed to prepare cellblock material from the cytology specimen for immunocytochemistry, a diagnosis was not obtained.
Histological Findings
The cut surface of the lymph node obtained by biopsy was solid and light grayish in color without necrosis or hemorrhage (Fig. 3A) . Microscopically, large atypical cells were observed in the lymph node, similar to the results of cytodiagnosis (Fig. 3B ). These atypical cells had invaded the area outside the lymph node. The mitotic rate was high (58/10HPF) and atypical mitotic forms were observed (Fig. 3B) . Immunohistochemically, the tumor cells were positive for vimentin, CD68, and CD163 and focally positive for S-100 and CD1a (Figs. 3C-G) . Epithelial markers (AE1/AE3, CK7, CK20, and p40), lymphocyte markers (CD3, CD20, CD45, and CD79a), and melanoma markers (HMB45 and Melan-A) were negative (data not shown). The possibility of a proliferative disease of histiocytes was considered from the positive results for CD68, and the possibility of a malignant tumor was considered from the finding of extranodal invasion. LCS was diagnosed by a high mitotic rate with an atypical form and positivity for CD1a and CD163. Metastasis of LCS was confirmed by the autopsy in many organs including the heart, bilateral lungs, liver, pancreas, bilateral kidneys, left adrenal gland, spleen, bone marrow, and systemic lymph nodes.
Past Material and Genetic Test Findings
Our case was a case of quintuple cancers. The patient had two moderately differentiated adenocarcinomas (sigmoid colon, No genetic mutations of KRAS and BRAF V600E were detected in these five tumor materials, including the LCS.
Discussion
LCS is an extremely rare tumor, and it has a very poor prognosis. Our patient died about 2 months after the first medical examination. Early diagnosis is important to improve the prognosis. As described above, atypical tumor cells were observed in cytology, suggesting that the tumor was a histiocytic neoplasm. Although a diagnosis of LCS only by these cytological findings is difficult, 4 immunocytochemistry using cell block materials may be useful for an accurate preoperative diagnosis. In cases with the above-described cytological findings, LCS should be added to the list of differential diagnosis. If cellblock materials had been prepared in this case, they might have been useful for diagnosis. In addition, cytology can be very useful for staging of the disease and follow-up of the neoplasm. The cytological findings described in this report may be useful for determining appropriate clinical management in the future. Quintuple cancers are rare. [5] [6] [7] [8] [9] [10] [11] Our case had 3 epithelial cancers and 2 tumors of the hematopoietic and lymphoid tissues. It has been reported that KRAS gene mutation was found in colon adenocarcinoma 12 and that BRAF gene mutation was found in both LCS and colon adenocarcinoma. 4, 12 However, KRAS and BRAF gene mutations were not detected in our case. There have been several reports on LCS arising from other tumors of hematopoietic and lymphoid tissues. [13] [14] [15] [16] However, there has been no report on LCS related to T-cell/histiocyterich large B-cell lymphoma. Some novel genetic mutations that can give rise to multiple neoplasms might have been hidden in his background.
